H.C.R. No. 30 Summary

• Urges Congress to end the federal ban on funding syringe exchange programs (SEPs) that has been in place since 1988.

• Cites that 8,000 people are newly infected with HIV and 15,000 with hepatitis C annually through sharing contaminated syringes, and that SEPs reduce transmission of blood-borne infections.

• Notes SEPs are cost-effective, with $385,200 in lifetime HIV treatment costs equivalent to funding that would prevent at least 30 new infections through SEPs.

• References endorsement of SEPs by major medical organizations including the American Medical Association, American Academy of Pediatrics, American Nurses Association, and others.

• Directs the House Clerk to send authenticated copies of the resolution to the President Pro Tempore of the Senate, Speaker of the House, HHS Secretary, and Ohio's Congressional delegation.